Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Wrist surgery pain study tests lower anesthetic dose

NCT ID NCT06950372

First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 7 times

Summary

This study looked at 80 adults having wrist fracture surgery to see if using a lower concentration of the numbing drug ropivacaine (3.75 mg/ml vs. 7.5 mg/ml) could reduce the intense "rebound pain" that often happens when the nerve block wears off. Participants received one of the two doses and reported their pain levels and medication use for up to 6 weeks after surgery. The goal was to find a way to make recovery more comfortable without affecting the success of the nerve block during the operation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RADIUS FRACTURE DISTAL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Oslo University Hospital

    Oslo, Norway

Conditions

Explore the condition pages connected to this study.